Intravenous tolvaptan equally safe and effective as oral formulation in severe acute heart failure patients: Study Medha Baranwal5 July 2024 9:45 AM ISTJapan: In a new study focusing on the management of acute decompensated heart failure (ADHF), researchers have compared the efficacy and safety of...
Semaglutide Shines in Kidney Health Across Diabetes Patients: Study Highlights Consistency and Potential Medha Baranwal5 July 2024 9:15 AM ISTGermany: A recent clinical trial, known as the FLOW trial, has provided significant insights into treating type 2 diabetes and chronic kidney disease...
Antiseizure medications can produce life-threatening reactions, claims study Dr. Kamal Kant Kohli4 July 2024 9:15 PM ISTTargeted blood tests, asking patients about risk factors, and dose modifications can lessen the risk of potentially fatal reactions to antiseizure...
Popular weight loss drug Semaglutide linked to uncommon blinding condition, reveals JAMA study Dr. Kamal Kant Kohli4 July 2024 7:30 PM ISTInvestigators at Mass Eye and Ear have found in a new study have found that patients who were prescribed semaglutide for diabetes or weight loss...
Zydus Lifesciences BP lowering drug receives USFDA tentative nod Ruchika Sharma4 July 2024 4:46 PM ISTAhmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) to market...
Semaglutide effects greater weight loss in women than men with HF, improves HF symptoms in both sexes, suggests study Dr. Kamal Kant Kohli4 July 2024 9:00 AM ISTSemaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of...
New Genetic Study Highlights Oxytocin's Role in Treating Obesity and Postnatal Depression Anshika Mishra4 July 2024 8:15 AM ISTScientists have identified a gene that, when missing or impaired, can cause obesity, behavioral problems and, in mothers, postnatal depression. The...
FDA approves another drug for treatment of adults with early symptomatic Alzheimer's disease Dr. Kamal Kant Kohli3 July 2024 8:30 PM ISTThe US Food and Drug Administration has approved aother drug donanemab (Kisunla) for treatment of adults with early symptomatic Alzheimer's disease...
Lipoprotein(a) Levels Linked to Increased Risk of In-Stent Restenosis Post-PCI: New Study Reveals Medha Baranwal3 July 2024 10:00 AM ISTUSA: Recent research has shed light on the connection between lipoprotein(a) levels and the long-term risk of in-stent restenosis (ISR) following...
Use of glucose monitors by people not living with diabetes needs more regulation: Study Dr. Kamal Kant Kohli3 July 2024 9:00 AM ISTA new narrative review led by researchers at UCL and Birmingham Children's Hospital has found there is a lack of evidence to demonstrate the effective...
New Genetic Research Links Early Puberty in Girls to Weight Gain Anshika Mishra3 July 2024 8:30 AM ISTA Cambridge-led study has discovered that genes can indirectly influence the age at which girls experience their first period by accelerating...
Could preventative drug be effective in people with migraine and rebound headache? Dr. Kamal Kant Kohli3 July 2024 7:30 AM IST A drug used to prevent migraine may also be effective in people with migraine who experience rebound headaches, according to a new study...
